Depression Care360

In part 1 of this interview, Patricia Pelufo Silveira, MD, PhD, Associate Professor at McGill University, discusses the results of her recent study.

In this clip from Psych Congress 2022 in New Orleans, Louisiana, Mark Zimmerman, MD, professor at Brown University, discusses focusing on the whole patient when treating people with depression as well as...

At Psych Congress 2022, Samantha Lau, NP, steering committee member and founder of ELEVATEHER, discussed what makes ketamine different from other depression treatments.

Manish K. Jha, MBBS, and Saundra Jain, MA, PsyD, LPC, discuss their Psych Congress 2022 session "Measurement-Based Care in Depression and Beyond: What is it and how to make it work for your patients?" and...

Manish K. Jha, MBBS, and Saundra Jain, MA, PsyD, LPC, discuss their Psych Congress 2022 session "Measurement-Based Care in Depression and Beyond: What is it and how to make it work for your patients?" and...

Ben Medrano, MD, and Michael J Verbora, MD, MBA discuss what patient populations are benefiting most from intravenous (IV) ketamine treatment and what populations could be potentially harmed by the...

Ben Medrano, MD, and Michael J Verbora, MD, MBA discuss what patient populations are benefiting most from intravenous (IV) ketamine treatment and what populations could be potentially harmed by the...

Vladimir Maletic, MD, MS,  explores the effects of social relationships, including loneliness and isolation, on the brain and the body.

Vladimir Maletic, MD, MS,  explores the effects of social relationships, including loneliness and isolation, on the brain and the body.

In this video, Charles Conway, MD, summarizes new research supporting the use of nitrous oxide for the treatment of treatment-resistant major depression (TRMD).